- In second reversal, FDA gives uniQure a green light to seek accelerated approvalRegulatory flexibility appears to be back on the FDA’s menu following the departures of Marty Makary and Vinay Prasad. At the center of the debate, once again, is the ...Endpoints · 1mo ago↗ source
- Jazz zeroes in on next-gen T cell engagers with AbCellera dealThe potentially $4 billion collaboration is the latest example of drugmakers working to broaden the use of T cell engagers, which, so far, have had limited success outside of certain blood cancers.BioPharma Dive · 1mo ago↗ source
- STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcommUniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech newsSTAT